Selected data models

You must log in to select data models for download or further analysis.

96 Search results.
Relevance Rating New first Old first

Laboratory Visit 05 SirTac NCT02936388 - Laboratory Visit 05

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 05. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 06 SirTac NCT02936388 - Laboratory Visit 06

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 01 SirTac NCT02936388 - Laboratory Visit 01

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 01. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory 6- Weeks Visits SirTac NCT02936388 - Laboratory 6- Weeks Visits

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 08 SirTac NCT02936388 - Laboratory Visit 08

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 04 SirTac NCT02936388 - Laboratory Visit 04

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 04. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 07 SirTac NCT02936388 - Laboratory Visit 07

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Visit 03 SirTac NCT02936388 - Laboratory Visit 03

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Laboratory Before every SIRT- or TACE- Treatment

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Screening Day -7 to 0 SirTac NCT02936388 - Laboratory Screening Day -7 to 0

- 1/31/22 - 1 form, 1 itemgroup, 28 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory Screening Day -7 to 0 SirTac NCT02936388 - Laboratory Screening Day -7 to 0

- 1/31/22 - 1 form, 1 itemgroup, 28 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Laboratory 12- Weeks Visits SirTac NCT02936388 - Laboratory 12- Weeks Visits

- 1/31/22 - 1 form, 1 itemgroup, 29 items, 1 language
Itemgroup: Laboratory
Study part: Laboratory 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial